25
Feb
Chemence Medical Receives FDA Clearance for Exofin® Tissue Adhesive
Alpharetta, Georgia – February 15, 2016 Chemence Medical, Inc., a manufacturer and distributor of adhesive-based medical devices, announced it received Food and Drug Administration clearance to market and sell Exofin®, a new topical skin adhesive for wound closure. Exofin enters the market as the fastest polymerizing 2-octyl cyanoacrylate topical adhesive available and as the highest … Chemence Medical Receives FDA Clearance for Exofin® Tissue Adhesive